Article | September 21, 2022

AI In Data Management

AI-Artificial Intelligence GettyImages-1244482898

Growing amounts of collected clinical data augment the importance of reassessing the methods used for data processing and managing. Risk-based monitoring of the collected data is an integral part of any quality management program, it is an obligatory demand of the regulatory agencies and it substantially contributes to reducing the probability of costly failures (Hawwash, Applied Clinical Trials, 2018). However, typically, it is slow and expansive. The industry has been successful in reducing costs with the risk-based monitoring approach, where only sites who carry high risk, or their data has shown to fall outside expected monitoring trends, are targeted for regular monitoring visits. Based on this success, discussions have started around the thought of risk-based data management activities.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Bioforum the Data Masters Inc.